A multicentre, phase III, randomised, double-blind, placebo-controlled trial of pravastatin added to first-line chemotherapy in patients with small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn56306957 ◽

2012 ◽

Author(s):

Michael Seckl

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

A multicentre phase III randomised double-blind placebo controlled trial of pravastatin added to first-line chemotherapy in patients with non-small cell lung cancer (LungStar 2 trial)

http://isrctn.org/> ◽

10.1186/isrctn45605573 ◽

2013 ◽

Author(s):

Michael Seckl

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8036 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8036-8036 ◽

Author(s):

Peter Michael Ellis ◽

Geoffrey Liu ◽

Michael Millward ◽

Francesco Perrone ◽

Frances A. Shepherd ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Prior Chemotherapy ◽

Download Full-text

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

British Journal of Cancer ◽

10.1038/bjc.1998.100 ◽

1998 ◽

Vol 77 (4) ◽

pp. 627-631 ◽

Author(s):

L Wood ◽

M Palmer ◽

J Hewitt ◽

R Urtasun ◽

E Bruera ◽

...

Keyword(s):

Small Cell Lung Carcinoma ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Cell Lung Carcinoma ◽

Double Blind Placebo ◽

Download Full-text

C1-03: A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283190.70038.e9 ◽

2007 ◽

Vol 2 (8) ◽

pp. S359 ◽

Author(s):

Siow-Ming Lee ◽

Penella J. Woll ◽

Robin M. Rudd ◽

Nicole H. Gower ◽

Christian H. Ottensmeier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

118TiP A multicenter, randomized, double-blind, placebo-controlled phase III trial of camrelizumab plus chemotherapy with or without radiation therapy (RT) as first-line treatment for patients with brain metastatic non-small cell lung cancer (BM-NSCLC; CTONG2003): Trial in progress

Annals of Oncology ◽

10.1016/j.annonc.2021.10.136 ◽

2021 ◽

Vol 32 ◽

pp. S1426-S1427

Author(s):

J. Yang ◽

Y. Pan ◽

F. Ning ◽

L. Lin ◽

X. Hu ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

First Line Treatment

Download Full-text

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00483-0 ◽

2016 ◽

Vol 17 (2) ◽

pp. 212-223 ◽

Author(s):

Elisabeth Quoix ◽

Hervé Lena ◽

Gyorgy Losonczy ◽

Frédéric Forget ◽

Christos Chouaid ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Line Chemotherapy

Download Full-text

Double blind, placebo controlled trial of oral lactoferrin in combination therapy for first line non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7141 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7141-7141

Author(s):

Y. Wang ◽

E. Yankee ◽

A. Varadhachary

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn16174527 ◽

2013 ◽

Author(s):

Siow Ming Lee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)

European Journal of Cancer ◽

10.1016/j.ejca.2015.04.026 ◽

2015 ◽

Vol 51 (12) ◽

pp. 1511-1528 ◽

Author(s):

Mary E.R. O’Brien ◽

Rabab Gaafar ◽

Baktiar Hasan ◽

Jessica Menis ◽

Tanja Cufer ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Lung Cancer Patients ◽

Cancer Group ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

Cancer Treatment Reviews ◽

10.1016/s0305-7372(03)00020-3 ◽

2003 ◽

Vol 29 (2) ◽

pp. 127-129 ◽

Author(s):

B Coudert

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Double Blind ◽

European Organization ◽

Line Chemotherapy

Download Full-text